Benzinga's Top Initiations

by Monica Gerson, Benzinga Staff Writer

August 1, 2014 9:22 AM | 1 min read | Make a Comment

Analysts at Roth Capital initiated coverage on Alcobra Pharma

ADHD

with a Buy rating. The target price for Alcobra Pharma is set to $40. Alcobra Pharma's shares closed at $17.42 yesterday. Jefferies initiated coverage on The Finish Line

FINL

with a Buy rating. The target price for The Finish Line is set to $33. The Finish Line's shares closed at $26.29 yesterday. Analysts at JP Morgan initiated coverage on shares of Sangamo BioSciences

SGMO

with a Overweight rating. The target price for Sangamo BioSciences is set to $22. Sangamo BioSciences' shares closed at $11.88 yesterday. Roth Capital initiated coverage on shares of Sucampo Pharmaceuticals

SCMP

with a Buy rating. The target price for Sucampo Pharmaceuticals is set to $9. Sucampo Pharmaceuticals' shares closed at $5.90 yesterday.

Market News and Data brought to you by Benzinga APIs